Civil Society Involvement in Drug Policy


Civil Society Involvement in Drug Policy (CSIDP) aims at eliminating these obstacles to eliminate meaningful civil society involvement (CSI) in the development and implementation of drug policies on national and European levels.

In this regard, the project contributes to the European Drug Strategy and Action Plans and the work of civil society. It will improve processes and results in genuine and meaningful civil society involvement. It will increase the quality, social support and final impact of the strategy and action plans to develop health- and rights-based drug policies. With a structural and formalised CSI, national policies will be better equipped to contribute to a measurable reduction of drug-related health and social risks and harms. Structural and formalised CSI also contributes to  better dissemination of monitoring, research and evaluation results and a better understanding of all aspects of the drugs phenomena and on the impact of interventions in order to provide sound and comprehensive evidence-base for policies.

In order to enhance CSI, we will

  • Assess CSI within Europe. With this assessment we will investigate what activities are taken place on the CSI front and which methods are being used.
  • Develop a roadmap for CSOs and policy makers with guidance for a successful CSI.
  • Develop and implement national action plans on a pilot scale in six European countries
  • Organise six national and a European CSI event

In the long run, we aim to

  • Provide stakeholders with guidance to stimulate and support effective CSI.
  • Raise awareness on the relevance and importance of CSI on national and European levels.


The Regenboog Group (RG) is the main applicant of the project.

RG is an Amsterdam-based NGO committed to people with social problems, such as homelessness, drug and alcohol use and psychiatric disorders. RG is the host of Correlation – European Network Social Inclusion & Health.

The Centre for Interdisciplinary Addiction Research of the Hamburg University (ZIS)

has a sound record of successfully implemented projects on national, European and international level.
The ZIS conducts practice-oriented research in the field of drug policy, drug treatment, harm reduction, monitoring and health promotion for a variety of vulnerable groups such as prisoners, sex workers, women, ageing drug users. It also organises conferences, capacity building seminars and provides education to health professionals.

Apdes (Portugal), Ana Liffey (Ireland), Droghe Forum (Italy), Lila (Italy), Initiative of Health (Bulgaria)

are all leading CSOs in their country, working with marginalized groups and people and engaging in political dialogue.

  • Ana Liffey also provides the chair of the civil society working group in the current CSF on Drugs.
  • Lila provided the co-chair of the Civil society Forum on HIV/AIDS.


is a research institute in Slovenia, engaged in national and European projects, also chairing the working group on quality standards at the Civil society Forum on Drugs.

A number of relevant European Networks support the activities:

  • European Civil Society Forum on Drugs
  • European Civil Society Forum on HIV/AIDS
  • International Drug Policy Consortium
  • Harm Reduction International (European Harm Reduction Network),
  • European Network of People Who Use Drugs
  • European AIDS Treatment Group


4 + 15 =

Your contact information will only be stored for the purpose of sending information on the conference. Your personal data can be deleted at any time upon request.


Civil Society Involvement in Drug Policy (CSIDP)
c/o Foundation De REGENBOOG GROEP
tel. +31 20 570 7826 (direct)
Droogbak 1d
1013 GE Amsterdam
The Netherlands


 Co-funded by the European Union